Wolverine Trading’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,100
Closed -$231K 5480
2021
Q4
$231K Sell
5,100
-6,900
-58% -$360K ﹤0.01% 4499
2021
Q3
$726K Buy
+12,000
New +$914K ﹤0.01% 3423
2021
Q2
Sell
-7,800
Closed -$491K 6072
2021
Q1
$491K Sell
7,800
-23,900
-75% -$1.86M ﹤0.01% 3720
2020
Q4
$2.38M Buy
+31,700
New +$1.84M ﹤0.01% 1555
2020
Q2
Sell
-9,700
Closed -$217K 4616
2020
Q1
$217K Sell
9,700
-5,300
-35% -$119K ﹤0.01% 3597
2019
Q4
$315K Sell
15,000
-4,000
-21% -$91.8K ﹤0.01% 3531
2019
Q3
$415K Sell
19,000
-12,200
-39% -$338K ﹤0.01% 2823
2019
Q2
$1.12M Buy
+31,200
New +$999K ﹤0.01% 1941
2019
Q1
Sell
-13,200
Closed -$310K 4573
2018
Q4
$310K Sell
13,200
-6,000
-31% -$154K ﹤0.01% 3145
2018
Q3
$554K Buy
+19,200
New +$359K ﹤0.01% 2997

Other funds holding CDNA

Wolverine Trading's CDNA Position: Q1 2022 in Review

Wolverine Trading sold out of CareDx (CDNA) in Q1 2022, closing a stake of 8,176 shares — an estimated $370K sold.

Wolverine Trading first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $850K in Q3 2018. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Wolverine Trading reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 8,176 CareDx shares in Q1 2022, an estimated $370K.
  • Wolverine Trading first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • Wolverine Trading's CareDx position peaked at $850K in Q3 2018.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.